HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Myocardial excitability under the influence of digitalis glycosides and anti-arrhythmia agent].

Abstract
Using the technical procedure of transvenous cardiac pacing right ventricular myocardium was stimulated with various pulse duration (voltage-duration curves) and with paired stimuli utilizing double pacing technique, to determine diastolic threshold profile up to the absolute refractory period. Two kinds of cardiac drugs were tested: Digitalis glycosides increase distolic excitability and shorten refractory period. Anitarrhythmic drugs have different effects: Lidocaine and Phenytoine in several cases decrease slightly the stimulatory threshold and can shorten the refractory period. Procainamide and Ajmaline prolong the refractory period and increase the stimulatory threshold. Propranolol and Verapamil have no significant effect. Their major action is supraventricular. The results are important in view of clinical pharmacology of cardiac drugs and of long term cardiac pacemaker therapy.
AuthorsV P Doenecke
JournalFortschritte der Medizin (Fortschr Med) Vol. 95 Issue 3 Pg. 163-6 (Jan 20 1977) ISSN: 0015-8178 [Print] Germany
Vernacular TitleDie myokardiale Erregbarkeit unter dem Einfluss von Digitalisglykosiden und Antiarrhythmika.
PMID838426 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Digitalis Glycosides
  • Ajmaline
  • Phenytoin
  • Digoxin
  • Lidocaine
  • Propranolol
  • Verapamil
  • Procainamide
Topics
  • Ajmaline (pharmacology)
  • Anti-Arrhythmia Agents (pharmacology)
  • Digitalis Glycosides (pharmacology)
  • Digoxin (pharmacology)
  • Heart Conduction System (drug effects)
  • Humans
  • Lidocaine (pharmacology)
  • Myocardial Contraction (drug effects)
  • Phenytoin (pharmacology)
  • Procainamide (pharmacology)
  • Propranolol (pharmacology)
  • Refractory Period, Electrophysiological
  • Stimulation, Chemical
  • Verapamil (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: